Merck nears a $6bn all-cash acquisition of Terns Pharma and its CML drug TERN-701. Here’s the full strategic picture—what it means for patients, investors, and Big...
Beijing’s export-control probe into Meta’s acquisition of the agentic AI startup is the sharpest test yet of who owns the talent and technology produced by China’s...
The city-state’s leader heads to “Asian Davos” as US-China rivalry reshapes every calculation in the Indo-Pacific Every March, the small coastal town of Boao in China’s...
China’s 15th Five-Year Plan (2026–2030) maps a breathtaking tech transformation — humanoid robots, fusion power, 6G brain interfaces, and 109 mega-projects. Here’s what it means for...
A landmark 2026 study reveals eroding trust, sovereignty anxieties, and a bloc struggling to justify its existence to the very peoples it claims to serve. When...
When Ares Management honored every single redemption request from its flagship retail credit vehicle in the fourth quarter of 2024 — voluntarily absorbing outflows above its...
There is a particular kind of corporate ambition that does not announce itself. It assembles a small team. It watches. It waits for the moment when...
The machines are already choosing who dies. The question is whether humanity will choose to stop them. In the early weeks of Israel’s military campaign in...
The Iran conflict has turned frontier AI models into contested weapons of state — and the financial and human fallout is only beginning to register. In...
As Brent crude climbs above $85 a barrel and the Strait of Hormuz trembles under the weight of geopolitical crisis, Southeast Asia’s largest economy is walking...